
Tailored Brands Announces Leadership Change
Peter Sachse, current Tailored Brands Chief Executive Officer and forthcoming Executive Chairman, stated, 'Since joining us in 2021, Brandy has contributed to our successful business and financial transformation. With a strong foundation in place, I'm confident that with our talented leadership and finance teams we are well-positioned to execute our future growth plans and build on our momentum. I appreciate Brandy's partnership and leadership over the years and wish her continued success in her next chapter.'
About Tailored Brands, Inc.
Tailored Brands is a leading omnichannel specialty retailer of menswear, including suits, formalwear and a broad selection of business casual offerings. We help our customers love the way they look and feel by delivering personalized products and services through our convenient network of stores and e-commerce sites. Our brands include Men's Wearhouse, Jos. A. Bank, Moores and K&G Fashion Superstore.
For additional information on Tailored Brands, please visit the Company's websites at www.tailoredbrands.com, www.menswearhouse.com, www.josbank.com, www.mooresclothing.ca, and www.kgstores.com.
Forward-Looking Statements
This press release contains forward-looking information, including the Company's statements regarding its strengthened business and growth outlook and the Company's ability to execute on its strategic initiatives. In addition, words such as 'will,' 'expects,' 'anticipates,' 'envisions,' 'targets,' 'goals,' 'projects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' 'guidance,' 'may,' 'projections,' and 'business outlook,' variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements that we make herein are not guarantees of future performance and actual results may differ materially from those in such forward-looking statements as a result of various factors. Factors that might cause or contribute to such differences include, but are not limited to: risks related to the effectiveness of the restructuring and strategic activities completed during and subsequent to the Company's Chapter 11 process and any additional strategies that the Company may employ to address its business including its liquidity and capital resources; risks and uncertainties related to government export and import policies, such as the impact of international trade disputes and the risks associated with potential changes to international trade agreements, including the imposition or threat of imposition of new or increased tariffs or retaliatory tariffs implemented by other countries as well as the imposition of additional duties on the products we import; the Company's ability to attract, motivate and retain key personnel and effectively manage succession; success, or lack thereof, in formulating or executing our internal strategies and operating plans; cost reduction initiatives and revenue enhancement strategies; changes in demand for our retail clothing or rental products, including changes in apparel trends and changing consumer preferences; market trends in the retail or rental business; customer confidence and spending patterns; changes in traffic trends in our stores and in customer preferences in the omnichannel experience; customer acceptance of our merchandise strategies, including custom clothing and polished casual attire, and other initiatives; disruptions in our supply chain; performance issues and other changes with key suppliers; severe weather; regional, national or global civil unrest or acts of civil disobedience; public health crises, including COVID-19; foreign currency fluctuations; advertising or marketing activities of competitors; the impact of climate change, cybersecurity threats or data breaches; and the impact of legislation, tax, regulatory or legal proceedings.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
4 minutes ago
- Business Wire
Amplitude Surgical – Consolidated annual revenue of €110.8 million, up +5.7% at constant exchange rates
VALENCE, France--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME), the French leader in surgical technologies for lower limb orthopedics, announces its consolidated revenue for the 2024-25 fiscal year. Olivier Jallabert, CEO of Amplitude Surgical, said: "The Group's revenue for the 2024-25 fiscal year shows an increase of +5.7% at constant exchange rates compared to the previous fiscal year. Amplitude Surgical has thus recorded another year of growth, both in France, with a 4.8% increase in revenue, and internationally, with an 8.2% increase in activity at constant exchange rates." Consolidated revenue for the 2024-25 financial year Revenue 2024-25 June 30, 2025 June 30, 2024 Change at current rates Change at constant rates In K€ - IFRS standards Knee and hip activities 110,833 106,019 4.5% 5.7% Total 110,833 106,019 4.5% 5.7% Expand Revenue Q4 2024-25 June 30, 2025 June 30, 2024 Change at current rates Change at constant rates In K€ - IFRS standards Knee and hip activities 27,020 26,406 2.3% 3.8% Total 27,020 26,406 2.3% 3.8% Expand During the 2024-25 financial year, Amplitude Surgical's revenue amounted to €110.8 million, up 4.5% at current exchange rates and 5.7% at constant exchange rates. Revenue for the 2024-25 financial year was therefore slightly below the outlook published in March 2025, with fourth-quarter growth more moderate than the trend observed for the first nine months of the financial year and unfavorable exchange rate effects, particularly in Australia. During the 2024-25 financial year, business in France grew by +4.8%, while international distributors posted growth of +2.9% and the Group's international subsidiaries recorded an increase of +4.1% at current rates and +10.0% at constant rates. Amplitude Surgical's direct business (French market and international subsidiaries), which accounts for nearly 93% of the Group's total sales, grew by 6.0% at constant exchange rates. France accounts for approximately 73% of the Group's business. For international subsidiaries, business grew at constant rates in Belgium, Australia, Brazil, and South Africa, while Switzerland and Germany reported a decline in commercial activity. EBITDA margin 2024-25 In its press release issued on March 26, 2025, the Company updated its outlook and anticipated an EBITDA margin of approximately 26.5% for the fiscal year ending June 30, 2025. Based on unaudited financial statements as of the date of this press release, the Company anticipates an EBITDA margin of approximately 27%. Next press release: 2024-25 annual results: Wednesday, October 22, 2025, after market close. About Amplitude Surgical Founded in 1997 in Valence, Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main pathologies affecting the hip and knee. Amplitude Surgical develops, in close collaboration with surgeons, a number of high value-added innovations to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is expanding internationally through its subsidiaries and a network of exclusive agents and distributors in more than 30 countries. As of June 30, 2025, Amplitude Surgical employed 429 people and generated revenue of nearly €111 million.


Business Wire
4 minutes ago
- Business Wire
Medincell: Half-Year Liquidity Contract Statement
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Under the liquidity contract entrusted by Medincell (Paris:MEDCL) to Rothschild Martin Maurel, the following resources were included in the liquidity account at June 30, 2025: 5 000 shares 1 145 177 € Over the period from 01/01/2025 to 30/06/2025, a total of : Number of executions Number of shares Traded volume in EUR Buy side 11,807 759,363 11,677,812.97 Sell side 11,343 758,413 11,671,875.50 Expand It should be noted that Medincell increased the funds allocated to the liquidity contract by €600,000 on 11 April 2025. At the time of its implementation on September 11, 2024, the following resources were included in the liquidity account: 8 824 shares 466 568.49 € About Medincell Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable drugs in many therapeutic areas. Our innovative treatments aim to guarantee compliance with medical prescriptions, to improve the effectiveness and accessibility of medicines, and to reduce their environmental footprint. They combine active pharmaceutical ingredients with our proprietary BEPO® technology which controls the delivery of a drug at a therapeutic level for several days, weeks or months from the subcutaneous or local injection of a simple deposit of a few millimeters, entirely bioresorbable. The first treatment based on BEPO® technology, intended for the treatment of schizophrenia, was approved by the FDA in April 2023, and is now distributed in the United States by Teva under the name UZEDY® (BEPO® technology is licensed to Teva under the name SteadyTeq™). We collaborate with leading pharmaceutical companies and foundations to improve global health through new treatment options. Based in Montpellier, Medincell currently employs more than 140 people representing more than 25 different nationalities. UZEDY® and SteadyTeq™ are registered trademarks of Teva Pharmaceuticals. This press release may contain forward-looking statements, particularly concerning the progress of the Company's clinical trials. Although the Company considers that its forecasts are based on reasonable assumptions, any statements other than statements of historical fact that may be contained in this press release relating to future events are subject to change without notice, to factors beyond the Company's control and to the Company's financial capabilities. These statements may include, but are not limited to, any statements beginning with, followed by or including words or expressions such as "objective", "believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan", "project", "will", "may", "probably", "should", "could" and other words or expressions of similar meaning or used in the negative. Forward-looking statements are subject to inherent risks and uncertainties beyond the Company's control which may cause actual results, performance or achievements of the Company to differ materially from those anticipated or implied by such statements. A list and description of such risks, hazards and uncertainties can be found in the documents filed by the Company with the Autorité des Marchés Financiers (AMF) pursuant to its regulatory obligations, including in the Company's document de base, registered with the AMF on September 4, 2018 under number I. 18-062, as well as in documents and reports to be published subsequently by the Company. Furthermore, these forward-looking statements only apply as of the date of this press release. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, the Company undertakes no obligation to publicly update these forward-looking statements, nor to update the reasons why actual results may differ materially from those anticipated in the forward-looking statements, even if new information becomes available. The Company's updating of one or more forward-looking statements does not imply that it will or will not update these or any other forward-looking statements. This press release is published for information purposes only. The information contained herein does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for securities of the Company in any jurisdiction whatsoever, particularly in France. Similarly, this press release does not constitute investment advice and should not be treated as such. It is not intended to address the investment objectives, financial situation or specific needs of any particular recipient. It should not be relied upon as a substitute for the exercise of your own judgement. All opinions expressed in this document are subject to change without notice. The distribution of this press release may be restricted by law in certain jurisdictions. Persons into whose possession this press release comes are required to inform themselves about and to observe any such restrictions. Appendices – Rothschild Martin Maurel from 01/01/2025 to 30/06/2025 DATE NB_BUY NB_SALE QTE_BUY QTE_SALE CAPITAL_BUY CAPITAL_SALE 02/01/2025 89 132 1,607 5,257 26,949.39 89,631.85 03/01/2025 65 61 2,170 2,570 38,343.90 45,900.20 06/01/2025 111 85 3,509 2,609 63,758.53 47,562.07 07/01/2025 135 116 7,131 4,281 126,432.63 75,688.08 08/01/2025 63 66 3,356 3,356 57,924.56 58,025.24 09/01/2025 86 52 3,965 1,715 67,167.10 29,103.55 10/01/2025 70 43 2,336 1,336 39,011.20 22,391.36 13/01/2025 110 76 2,580 2,830 41,899.20 45,987.50 14/01/2025 50 51 1,848 1,848 30,196.32 30,362.64 15/01/2025 57 55 1,708 1,708 27,891.64 28,011.20 16/01/2025 31 51 2,238 3,238 36,277.98 52,585.12 17/01/2025 42 51 1,063 1,813 17,199.34 29,424.99 20/01/2025 47 32 1,971 1,971 32,028.75 32,068.17 21/01/2025 243 133 7,060 7,560 113,736.60 128,822.40 22/01/2025 48 75 1,456 2,706 23,179.52 43,323.06 23/01/2025 59 53 2,014 2,264 31,962.18 36,020.24 24/01/2025 44 98 1,850 2,810 29,507.50 45,044.30 27/01/2025 47 54 1,495 2,535 23,979.80 40,990.95 28/01/2025 61 135 555 1,555 9,301.80 25,828.55 29/01/2025 254 161 16,266 10,766 269,852.94 177,208.36 30/01/2025 226 230 16,770 16,520 259,767.30 256,060.00 31/01/2025 51 96 1,340 3,188 21,064.80 50,211.00 01/2025 1,989 1,906 84,288 84,436 1,387,432.98 1,390,250.83 03/02/2025 45 95 2,511 2,413 39,046.05 37,811.71 04/02/2025 48 47 2,065 2,065 32,895.45 32,978.05 05/02/2025 45 59 1,100 5,100 17,644.00 82,263.00 06/02/2025 41 39 1,826 1,826 29,928.14 29,946.40 07/02/2025 82 31 3,387 887 54,632.31 14,227.48 10/02/2025 161 69 4,812 2,062 74,537.88 32,167.20 11/02/2025 49 62 3,412 2,512 51,760.04 38,132.16 12/02/2025 52 38 1,643 1,793 24,743.58 27,038.44 13/02/2025 92 80 3,027 1,527 45,072.03 22,843.92 14/02/2025 156 160 4,414 3,414 63,164.34 48,547.08 17/02/2025 91 128 2,886 4,886 41,183.22 69,967.52 18/02/2025 144 95 3,940 3,403 55,238.80 47,744.09 19/02/2025 243 265 12,992 11,529 177,210.88 157,370.85 20/02/2025 245 126 3,818 4,318 52,039.34 59,070.24 21/02/2025 96 92 2,295 2,372 31,212.00 32,354.08 24/02/2025 78 54 1,618 1,541 22,020.98 21,065.47 25/02/2025 125 79 3,641 2,141 48,388.89 28,432.48 26/02/2025 240 295 6,989 11,489 95,819.19 160,156.66 27/02/2025 172 119 4,575 4,075 65,422.50 58,476.25 28/02/2025 110 109 2,625 2,625 37,170.00 37,511.25 02/2025 2,315 2,042 73,576 71,978 1,059,129.62 1,038,104.33 03/03/2025 80 110 832 2,532 11,964.16 36,435.48 04/03/2025 174 129 6,650 4,450 94,762.50 63,991.00 05/03/2025 117 266 8,281 11,081 119,163.59 159,677.21 06/03/2025 92 62 3,934 2,134 56,020.16 30,537.54 07/03/2025 122 153 8,000 7,000 112,320.00 98,280.00 10/03/2025 105 100 10,000 8,000 137,800.00 110,640.00 11/03/2025 84 77 3,416 2,156 46,491.76 29,450.96 12/03/2025 34 96 1,951 8,560 27,040.86 118,641.60 13/03/2025 106 94 7,706 5,757 107,421.64 80,425.29 14/03/2025 81 60 7,716 5,016 107,406.72 70,324.32 17/03/2025 71 114 7,879 10,921 109,518.10 152,020.32 18/03/2025 64 78 11,612 14,940 165,819.36 213,940.80 19/03/2025 91 112 11,437 11,808 166,865.83 172,396.80 20/03/2025 42 46 5,941 6,000 86,916.83 87,900.00 21/03/2025 71 87 9,902 9,152 147,935.88 137,005.44 24/03/2025 88 30 9,351 5,001 140,171.49 75,015.00 25/03/2025 67 56 4,661 3,961 69,029.41 58,662.41 26/03/2025 25 73 4,004 7,003 59,979.92 104,904.94 27/03/2025 67 45 6,457 4,558 96,467.58 68,005.36 28/03/2025 52 65 2,768 6,668 41,298.56 99,753.28 31/03/2025 91 30 7,061 1,361 102,808.16 20,006.70 03/2025 1,724 1,883 139,559 138,059 2,007,202.51 1,988,014.45 01/04/2025 106 93 8,067 6,567 115,922.79 94,433.46 02/04/2025 84 103 6,275 7,275 88,979.50 103,668.75 03/04/2025 55 27 4,332 3,422 61,124.52 48,318.64 04/04/2025 44 37 2,700 2,810 36,801.00 38,216.00 07/04/2025 2 3 150 570 1,923.00 7,341.60 08/04/2025 38 56 2,213 4,043 29,875.50 54,701.79 09/04/2025 63 50 4,913 3,463 64,311.17 45,053.63 10/04/2025 82 52 4,514 4,014 60,893.86 54,108.72 11/04/2025 74 50 4,515 3,690 58,559.55 47,970.00 14/04/2025 27 72 1,575 4,900 20,868.75 65,219.00 15/04/2025 31 57 1,525 4,025 21,106.00 55,625.50 16/04/2025 71 106 10,148 10,148 142,883.84 142,883.84 17/04/2025 54 66 4,844 4,844 68,300.40 68,494.16 22/04/2025 62 86 5,796 6,796 82,766.88 97,182.80 23/04/2025 121 110 10,326 10,326 150,966.12 151,172.64 24/04/2025 105 110 8,794 10,794 130,590.90 160,506.78 25/04/2025 115 58 9,039 4,039 136,217.73 60,544.61 28/04/2025 77 88 8,327 9,327 124,571.92 139,625.19 29/04/2025 96 107 10,750 10,750 160,927.50 161,250.00 30/04/2025 100 92 10,209 10,209 155,380.98 155,687.25 04/2025 1,407 1,423 119,012 122,012 1,712,971.91 1,752,004.36 02/05/2025 46 84 4,802 8,802 73,614.66 135,286.74 05/05/2025 102 103 10,750 9,500 164,045.00 145,350.00 06/05/2025 130 98 9,918 10,418 151,348.68 159,395.40 07/05/2025 110 92 7,131 7,881 109,104.30 120,894.54 08/05/2025 69 85 7,463 7,463 115,377.98 115,601.87 09/05/2025 48 36 4,721 4,721 73,553.18 73,600.39 12/05/2025 142 132 11,275 10,775 169,914.25 162,379.25 13/05/2025 113 92 11,500 10,000 174,455.00 151,700.00 14/05/2025 45 53 1,041 3,041 15,781.56 46,314.43 15/05/2025 69 13 5,050 1,050 77,063.00 15,960.00 16/05/2025 26 60 1,981 4,981 30,071.58 75,611.58 19/05/2025 52 44 3,166 4,166 49,421.26 65,072.92 20/05/2025 135 114 10,628 9,628 164,946.56 149,522.84 21/05/2025 50 80 3,791 4,791 59,025.87 74,979.15 22/05/2025 113 69 7,466 6,966 118,186.78 110,411.10 23/05/2025 145 141 5,722 5,722 91,609.22 92,410.30 26/05/2025 152 144 10,400 7,650 176,904.00 130,126.50 27/05/2025 85 125 8,270 10,020 140,259.20 170,039.40 28/05/2025 204 176 12,204 11,704 201,610.08 194,052.32 29/05/2025 145 123 12,000 9,357 199,680.00 155,887.62 30/05/2025 141 137 7,853 12,496 130,988.04 208,183.36 05/2025 2,122 2,001 157,132 161,132 2,486,960.20 2,552,779.71 02/06/2025 201 128 13,078 8,078 216,179.34 133,690.90 03/06/2025 193 156 10,185 10,657 164,589.60 173,282.82 04/06/2025 102 88 9,000 7,278 144,450.00 116,811.90 05/06/2025 89 139 5,250 11,500 84,892.50 186,415.00 06/06/2025 106 59 8,810 4,864 143,603.00 79,477.76 09/06/2025 83 76 6,319 6,223 101,040.81 99,692.46 10/06/2025 109 104 9,407 7,449 151,546.77 120,152.37 11/06/2025 134 73 10,000 4,000 158,300.00 63,360.00 12/06/2025 124 84 7,676 7,676 119,899.12 119,745.60 13/06/2025 158 128 9,356 9,356 144,363.08 144,456.64 16/06/2025 137 148 12,930 14,249 200,415.00 220,717.01 17/06/2025 99 53 11,926 3,624 181,871.50 55,048.56 18/06/2025 30 132 2,050 14,683 32,533.50 233,606.53 19/06/2025 64 103 5,849 9,699 95,748.13 159,548.55 20/06/2025 148 113 11,114 10,114 187,270.90 170,724.32 23/06/2025 101 84 12,940 9,440 223,991.40 163,123.20 24/06/2025 91 71 8,216 5,353 138,193.12 91,803.95 25/06/2025 58 123 4,825 8,688 81,397.75 147,087.84 26/06/2025 71 48 7,843 6,302 132,076.12 106,629.84 27/06/2025 67 106 9,209 12,750 155,816.28 216,495.00 30/06/2025 85 72 9,813 8,813 165,937.83 148,851.57 06/2025 2,250 2,088 185,796 180,796 3,024,115.75 2,950,721.82 S1/2025 11,807 11,343 759,363 758,413 11,677,812.97 11,671,875.50 Expand


Business Wire
4 minutes ago
- Business Wire
Generational Group Advises Unico Supply, Inc. on its Partnership with BizGro Partners
DALLAS--(BUSINESS WIRE)-- Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the strategic partnership of Unico Supply, Inc. and BizGro Partners. The acquisition closed March 24, 2025. Located in Houston, Texas, Unico Supply, Inc. is a premier provider of high-quality building materials, specializing in windows, doors, moldings, stair parts, natural stone, and hardware. Established in 2007, the company operates from a 50,000-square-foot showroom and warehouse, serving both new construction and remodeling projects. Unico Supply is dedicated to exceptional customer service, offering fast, friendly, and knowledgeable support throughout every stage of a project—from design and specification to ordering. With a strong focus on quality and value, Unico delivers top-tier materials at competitive prices to ensure clients receive the best return on their investment. Based in Cliffside Park, New Jersey, BizGro Partners is a private investment management firm specializing in acquiring and operating small to mid-sized B2B companies across sectors such as business services, wholesale distribution, manufacturing, and construction. With a portfolio of 34 companies across multiple U.S. states and a combined revenue exceeding $400 million, BizGro Partners focuses on creating productive partnerships to drive growth and generate sustainable wealth for all stakeholders. Generational Group Executive Managing Director, M&A, Central Region – Michael Goss, and his team led by Managing Director, M&A, Julio Dominguez. successfully closed the deal. Senior Managing Director of Private Client Group, Eric Matuszak established the initial relationship with Unico Supply, Inc. Ryan Binkley, CEO of Generational Group, added, 'At Generational Group, we are proud to facilitate such impactful transactions.' About Generational Group Generational Group, headquartered in Dallas, TX, is a leading, award winning full-service M&A advisory firm. Generational has over 300 professionals across 16 offices in North America. The firm empowers business owners to unlock the full value of their companies through a comprehensive suite of services—including strategic growth consulting, exit planning education, business valuation, value enhancement strategies, M&A advisory, digital solutions, and wealth management. Celebrating its 20 th year, Generational has successfully closed over 1,700 transactions and has ranked #1 or #2 in all LSEG league tables for deals valued between $25 million and $1 billion in 2022, 2023, and 2024. The firm was named 2024 USA Investment Banking Firm of the Year by the Global M&A Network and recognized as Investment Banking Firm of the Year by The M&A Advisor in both 2024 and 2022.